(19)
The amount in column (g) represents RSUs and associated accrued DEUs that will vest on December 31, 2010, should Mr. Nekritz be in our employ as of that date. The value in column (h) is based on the closing price of our common shares on December 31, 2007 of $63.38 per share.
OPTION EXERCISES AND STOCK VESTED FOR FISCAL YEAR 2007
Option Awards Number of Shares Acquired on Exercise (#) (b) Value Realized On Exercise ($) (c) Stock Awards Number of Shares Acquired on Vesting (#) (d) Value Realized On Vesting ($) (e)
Name (a)
Jeffrey H. Schwartz Walter C. Rakowich Ted R. Antenucci William E. Sullivan* Dessa M. Bokides* Edward S. Nekritz
9,425(1) 44,980(1) — — — — 53,110(4) — 4,712(1) —
$ 475,996(1) $2,132,883(1) $ — $ — $ — $ — $ 751,602(4) $ — $232,132(1) $ —
58,649(2) 39,881(2) 7,214(3) — 18,656(3) — 901(5) 44,118(6) 5,378(2) 1,804(3)
$3,678,038(2) $2,526,876(2) $ 436,695(3) $ — $1,177,804(3) $ — $ 59,196(5) $2,892,690(6) $ 340,929(2) $ 108,958(3)
* Mr. Sullivan became our chief financial officer on March 31, 2007. Ms. Bokides resigned as our chief financial officer effective March 31, 2007. The terms of the March 18, 2007 agreement with Ms. Bokides relating to her resignation are described below under “— Potential Payments upon Termination or Change in Control.”
(1)
The options to purchase our common shares in column (b) earned DEUs while they were outstanding which were distributed to the named executive officer upon exercise as follows: Mr. Schwartz — 5,192; Mr. Rakowich — 22,847; and Mr. Nekritz — 2,596. The value of these DEUs is not included in column (c). The value in column (c) is the aggregated difference between the market prices at which the named executive officer exercised the options and the exercise prices. The share awards in column (d) represent either RSUs, PSAs, or associated accrued DEUs that vested to the named executive officer in December 2007 that were scheduled to be distributed in January 2008. The value in column (e) is based on the closing price of our common shares on the respective vesting dates. The receipt of these awards was deferred by the named executive officer generally until January of the calendar year after the year in which the named executive officer’s employment with us terminates. However, certain of Mr. Schwartz’s deferred awards have specified dates of distribution. The deferral of these awards will be reflected as a 2008 contribution to the named executive officer’s deferred equity compensation account in next year’s proxy statement. The share awards in column (d) represent either RSUs, PSAs, or DEUs that vested to the named executive officer in December 2007 that were distributed in December 2007 or January 2008. The value in column (e) is based on the closing price of our common shares on the respective vesting dates. Under the terms of the agreement with Ms. Bokides relating to her resignation, Ms. Bokides vested in these previously unvested options. The value in column (c) is the aggregated difference between the market prices at which Ms. Bokides exercised her options and the exercise prices. Ms. Bokides vested in 901 RSUs and associated accrued DEUs in 2007, prior to her resignation as our chief financial officers and had previously elected to defer receipt of these awards until January of the calendar year after the year in which her employment with us terminated, which was January 2008. These share awards are reflected as a contribution to her deferred equity compensation account in 2007 in the Nonqualified Deferred Compensation for Fiscal Year 2007 table below. The value in column (e) is based on the closing price of our common shares on the vesting date. Under the terms of the agreement with Ms. Bokides relating to her resignation, Ms. Bokides vested in 44,060 of her previously unvested RSUs, PSAs, CPSs, and associated accrued DEUs. In addition, Ms. Bokides earned and was vested in 58 accrued DEUs associated with her vested RSUs that had previously been deferred. The value in column (e) is based on the closing price of our common shares on the date of her resignation for 44,060 awards and the closing price of our common shares on the vesting dates for the DEUs.
(2)
(3)
(4)
(5)
(6)
32